The vector of anti-MAGE-A3 T cell receptor (TCR) is constructed for the engineering of T cell to target Human MAGE-A3. The T cells are genetically modified through transduction with a lentiviral vector expressing MAGE-A3-specific T cell receptor. And the vector product was designed for the treatment of Melanmoma.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|VP-TCR-C247||Lenti-MAGE-A3 T cell receptor (TCRVα3/Vβ28) Viral Particle|
|VP-TCR-C246||Lenti-MAGE-A3 T cell receptor (TCRVα38/Vβ2) Viral Particle|
|TCR-C130Z||Human anti-MAGE-A3 T cell receptor (TCRVα3/Vβ28), pCDTCR1|
|VP-TCR-C251||Lenti-MAGE-A3 Murinized T cell receptor (6F9) Viral Particle|
|TCR-C128Z||Human anti-MAGE-A3 T cell receptor (ESBI 648), pCDTCR1|
|VP-TCR-C241||Lenti-MAGE-A3 T cell receptor (13-18) Viral Particle|
|TCR-L359||Human anti-MAGE-A3 T cell receptor (EB81-103), pCDTCR1|
|TCR-C125Z||Human anti-MAGE-A3 (EVDPIGHLY) T cell receptor (Affinity enhanced), pCDTCR1|
|VP-TCR-C243||Lenti-MAGE-A3 T cell receptor (6F9) Viral Particle|
|TCR-L061Z||Human anti-MAGEA3 (aa168-176) T cell receptor, pCDTCR1|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved